Journal
JOURNAL OF MOLECULAR MODELING
Volume 18, Issue 10, Pages 4739-4744Publisher
SPRINGER
DOI: 10.1007/s00894-012-1455-7
Keywords
Cancer; Docking; 3DU6; TERT; Telomerase inhibition
Categories
Funding
- University Grants Commission (UGC), New Delhi, India
Ask authors/readers for more resources
The activation of telomerase represents an early step in carcinogenesis. Increased telomerase expression in malignant tumors suggests that telomerase inactivation may represent a potential chemotherapeutic target. In this work, existing anticancer drugs were docked against telomerase reverse transcriptase (TERT) using a Lamarckian genetic algorithm (LGA). Autodock's scoring function was applied to each of the molecules in order to identify the inhibitor with the strongest pharmacological action. The structural insights provided by this study regarding binding poses and possible interactions, free energies of binding, and drug scores aided in the identification of potential inhibitory compounds. The ranks of the various ligands investigated were based on the final docked energy values. Among nine selected compounds, vindesine, temsirolimus, and cyclosporine were found to be more potent TERT inhibitors than the standard inhibitor, curcumin.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available